About the Webinar:
The U.S. Department of Justice announced a mandate to prosecutors to investigate corporate compliance programs of companies.
More acutely, specific instructions were provided to the prosecutors to investigate whether relevant data sources that enabled compliance teams to conduct audits, timely and effectively monitor, perform risk assessments, and test policies and transactions were available for the compliance professionals to leverage.
This directed compliance leaders to build data-driven compliance programs that are adequately resourced and empowered to function effectively to meet the updated DOJ’s requirements.
Key Takeaways:
- Understand DOJ’s latest compliance expectations for Life Sciences and Biotech.
- Learn practical steps for implementing a data-driven compliance program.
- Gain insights into competitive advantage through enhanced compliance capabilities.
- Actionable guidance on building compliant, data-supported processes for risk assessment and monitoring.
